[rVSVΔG-ZEBOV] Ebola Prevention Vaccine Evaluation in Sierra Leone
Phase of Trial: Phase II/III
Latest Information Update: 03 May 2017
At a glance
- Drugs RVSV-S-GP/VP40 vaccine (Primary)
- Indications Ebola virus infections
- Focus Adverse reactions
- Acronyms STRIVE
- 05 Apr 2017 Status changed from active, no longer recruiting to completed.
- 28 Dec 2016 According to an AIDS Healthcare Foundation media release, results from the study have been published in the journal Lancet.
- 28 Dec 2016 Results published in an AIDS Healthcare Foundation media release.